Federal Reserve Monetary Policy Stance Under Scrutiny Amid Inflation and Growth Concerns
Sun Pharma Reports 26 Profit Surge in Q4 FY2026 Proposes 5 Final Dividend
Accountants Emerging as Key Drivers of Corporate Sustainability ACCA Survey Indicates
Ofcom Raises Concerns TikTok and YouTube May Not Be Adequately Safe for Children
Trump Trade Czar Signals Tariffs on Canada Mexico Will Stay Despite USMCA
Taiwan Emerges as Pivotal Flashpoint in TrumpXi Summit Discussions
GTIM Q1 2026 Earnings Modest Profitability Amid Operational Challenges
MCO Q1 2026 Earnings EPS Surpasses Estimates Despite Modest Stock Decline
uniQure Q1 2026 Earnings NarrowerThanExpected Loss Amid No Revenue Stock Slips
ERO Q1 2026 Earnings Strong EPS Beat Driven by Operational Efficiency and Higher Copper Prices
QUAD Q1 2026 Earnings EPS Beats Estimates by 14 Stock Climbs Marginally
GOOGL Q1 2026 Earnings EPS Misses Estimates as Revenue Uncertainty Weighs on Sentiment
BlackRock Science and Technology Trust BST Advances 155 as Growth Stocks Find Favor
Bridger Aerospace Group Holdings Warrants BAERW Hover Near Support Amid Modest Decline
Idea Acquisition Corp Units IACOU Holds Steady Near 10 Amid Low Volatility
EPower Inc EPOW Slides 28 as Shares Test Key Support at 066
LivaNova LIVN Retreats 183 as Stock Faces Resistance Near 78 Zone
Micron Stock Surges Toward Best Month Since 1987 as Analysts See Further Value
Century Communities Q1 2026 Earnings Strong EPS Beat Amid Housing Market Headwinds
Prothena PRTA Edges Lower Near Support as Biotech Sector Faces Headwinds
XOMAO Q1 2026 Earnings EPS Misses Estimates by Wide Margin
CDP Q1 2026 Earnings EPS Surpasses Estimates with 2 Beat
Dana Incorporated DAN Q1 2026 Earnings EPS Misses Consensus Amid Mixed Operating Environment
Tetra Technologies TTI Q1 2026 Earnings EPS Beat Drives 81 Surprise Amid Revenue Disclosures Lacking
SNCY Q1 2026 Earnings EPS Misses Estimates Amid Operational Pressures
TSM Q1 2026 Earnings Strong EPS Beat Signals Robust Demand Amid Cautious Market Response
NGNE Q1 2026 Earnings EPS Misses Estimates as Biotech Continues RD Focus